This inventor holds 1 USPTO granted patent. Top assignees: Chapman University, Northeastern University, The University of Texas System. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Ilya Bezprozvanny: Innovator in Pharmaceutical Modulation
Introduction
Ilya Bezprozvanny is a notable inventor based in Austin, Texas. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate ion channels. His work has implications for various therapeutic areas, showcasing the importance of innovation in medicine.
Latest Patents
Bezprozvanny holds a patent for "SK channel positive allosteric modulators." This patent describes a compound according to Formula (I) or a pharmaceutically acceptable salt thereof. The formula includes various components, such as X being N or C—Y, where Y can be H, halogen, NH, OH, SH, alkyl, aryl, alkoxy, or aryloxy. Additionally, A can be O, NH, S, Se, or CH, while Z can be NH, CH, S, O, or Se. This innovative compound has the potential to advance therapeutic options in the pharmaceutical industry.
Career Highlights
Throughout his career, Bezprozvanny has worked with prestigious institutions, including Chapman University and The University of Texas System. His academic and research endeavors have positioned him as a key figure in the exploration of pharmaceutical innovations. His dedication to research and development has led to advancements that benefit the medical community.
Collaborations
Bezprozvanny has collaborated with notable colleagues, including Keykavous Parang and Naglaa Ibrahim. These partnerships have fostered a collaborative environment that enhances the research process and leads to groundbreaking discoveries.
Conclusion
Ilya Bezprozvanny's contributions to pharmaceutical modulation exemplify the impact of innovation in healthcare. His patent and collaborative efforts highlight the importance of research in developing new therapeutic solutions. His work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile